Summary
This study has examined the contribution of decrease in liver size to the decline in drug metabolising capacity which occurs with ageing. Liver volume and antipyrine kinetics were measured in two groups of healthy individuals aged 20 to 29 years and 75 to 86 years and in a group of hospitalised patients aged 70 to 89 years. Liver volume was reduced in both groups of elderly people compared to the young group. Antipyrine plasma half-life was prolonged and antipyrine clearance was reduced in the group of elderly normal individuals. In this group the index — antipyrine clearance per unit liver volume — was also reduced in comparison to that of the young group. Measurements of antipyrine elimination in the hospitalised elderly group did not differ significantly from those in the young group. It is concluded that both decreased liver mass and decreased hepatic enzyme activity contribute to the impairment of drug oxidation which occurs in the elderly and which may warrant a reduction in dosage of some drugs. However, differences have been demonstrated between groups of elderly people suggesting that under certain circumstances standard doses of such drugs may be normally tolerated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boyd, E.: Normal variability in weight of the adult human liver and spleen. Arch. Pathol.16, 350–372 (1933)
Branch, R. A., Herbert, C. M., Read, A. E.: Determinants of serum antipyrine half-lives in patients with liver disease. Gut14, 569–573 (1973)
Brodie, B. B., Axelrod, J., Soberman, R., Levy, B. B.: The estimation of antipyrine in biological material. J. biol. Chem.179, 25–79 (1949)
Brodie, B. B., Axelrod, J.: The Fate of Antipyrine in Man. J. Pharmacol. exp. Ther.98, 97–104 (1950)
Castleden, C. M., Kaye, C. M., Parsons, R. L.: The effect of age on plasma levels of propranolol and practolol in man. Br. J. clin. Pharmacol.2, 303–306 (1975)
Crooks, J., O'Malley, K., Stevenson, I. H.: Pharmacokinetics in the Elderly. Clin. Pharmacokinet.1, 280–296 (1976)
Edelman, I., Haley, H. B., Schloerb, P. R., Sheldon, D. B., Friis-Hansen, B. J., Stoll, G., Moore, C. D.: Further observations on total body water. Surg. Gynacol. Obstet.95, 1–12 (1952)
Farah, F., Taylor, W., Rawlins, M. D., James, O.: Hepatic drug acetylation and oxidation: effects of ageing in man. Br. med. J.1977/II, 155–156
Halliwell, M., Homeida, M., Roberts, C. J. C.: Value of liver volume measurement in the study of antipyrine kinetics in liver disease. Br. J. clin. Pharmacol.4, 393P (1977)
Homeida, M., Roberts, C. J. C., Halliwell, M., Jackson, L., Read, A. E.: Ultrasonic measurement of liver size. Br. med. J.1976/II, 6051–6052
Irvine, R. E., Grove, J., Toseland, P. A., Trounce, J. R.: Effect of age on the hydroxylation of amylobarbitone sodium in man. Br. J. clin. Pharmacol.1, 41–43 (1974)
Kato, R., Vassanelli, P., Frontino, G., Chiesara, E.: Variation in the activity of liver microsomal drug metabolising enzymes in rats in relation to age. Biochem. Pharmacol.13, 1037–1051 (1964)
Kato, R., Takanaka, A.: Effects of phenobarbital on electron transport system, oxidation and reduction of drugs in liver microsomes of rats of different ages. J. Biochem. (Tokyo)63, 406–408 (1968)
Krishnaswamy, K., Naidu, A. N.: Microsomal enzymes in malnutrition as determined by plasma half-life of antipyrine. Br. med. J.1977/I, 538–540
O'Malley, K., Crooks, J., Duke, E., Stevenson, I. H.: Effects of age and sex on human drug metabolism. Br. med. J.1971/III, 607–609
Roberts, C. J. C., Jackson, L., Halliwell, M., Branch, R. A.: The relationship between liver volume, antipyrine clearance before and after phenobarbitone administration in man. Br. J. clin. Pharmacol.3, 907–913 (1976)
Salem, S. A. M., Prajjayabyn, P., Shepard, A. M. M., Stevenson, I. H.: Reduced induction of drug metabolism in the Elderly. Age and Ageing7, 68–73 (1978)
Stevenson, I. H.: Factors influencing Antipyrine Elimination. Br. J. clin. Pharmacol.4, 261–265 (1977)
Thompson, E. N., Williams, R.: Effect of age on Liver Function with particular reference to Bromsulphthalein excretion. Gut6, 266–269 (1965)
Triggs, E. J., Nation, R. L.: Pharmacokinetics in the Aged: A Review. J. Pharmacokinet. Biopharm.3, 387–417 (1975)
Vesell, K. S., Page, J. C.: Genetic control of drug levels in man: Antipyrine. Science161, 72–73 (1968)
Vestal, R. E., Norris, A. H., Tobin, J. D., Cohen, B. H., Shock, N. W., Andres, R.: Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clin. Pharmacol. Ther.18, 425–432 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Swift, C.G., Homeida, M., Halliwell, M. et al. Antipyrine disposition and liver size in the elderly. Eur J Clin Pharmacol 14, 149–152 (1978). https://doi.org/10.1007/BF00607447
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00607447